These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 4942741)
21. The treatment of corticosteroid-dependent lepromatous patients in persistent Erythema nodosum leprosum with clofazimine. Imkamp FM Lepr Rev; 1973 Sep; 44(3):127-30. PubMed ID: 4788877 [No Abstract] [Full Text] [Related]
22. The treatment of leprosy. Waters MF Tubercle; 1983 Sep; 64(3):221-32. PubMed ID: 6356539 [No Abstract] [Full Text] [Related]
23. Clofazimine in leprosy. Browne SG Br Med J; 1972 Feb; 1(5798):506-7. PubMed ID: 4550304 [No Abstract] [Full Text] [Related]
24. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea. Cellona RV; Fajardo TT; Kim DI; Hah YM; Ramasoota T; Sampattavanich S; Carrillo MP; Abalos RM; dela Cruz EC; Ito T Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):1-11. PubMed ID: 2181040 [TBL] [Abstract][Full Text] [Related]
25. Effect of zafirlukast on leprosy reactions. Vides EA; Cabrera A; Ahern KP; Levis WR Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):71-5. PubMed ID: 10407633 [No Abstract] [Full Text] [Related]
26. Erythema nodosum leprosum in Nigeria. Somorin AO Int J Dermatol; 1975 Nov; 14(9):664-6. PubMed ID: 1184260 [TBL] [Abstract][Full Text] [Related]
27. A comparative evaluation of levamisole in leprosy. Sharma L; Thalliath GH; Girgia HS; Sen PC Indian J Lepr; 1985; 57(1):11-6. PubMed ID: 3839808 [TBL] [Abstract][Full Text] [Related]
28. A treatment of corticosteroid-dependent lepromatous patients in persistent erythema nodosum leprosum. A clinical evaluation of G.30320 (B663). Imkamp FM Lepr Rev; 1968 Jul; 39(3):119-25. PubMed ID: 4298736 [No Abstract] [Full Text] [Related]
29. [Clofazimine. Current status of therapy with clofazimine (Lampren) for leprosy, erythema leprosum , and other dermatoses after donation of the medicine to the WHO by Novartis]. Sunderkötter CH; Lan Ma H Hautarzt; 2005 May; 56(5):478-9. PubMed ID: 15806433 [No Abstract] [Full Text] [Related]
34. [Leprosy and the testis]. Rodríguez G; Abaúnza MC; Vargas EJ; López F Biomedica; 2012; 32(1):13-22. PubMed ID: 23235783 [TBL] [Abstract][Full Text] [Related]
35. Combined clofazimine- and dapsone-resistant leprosy. A case report. Kar HK; Bhatia VN; Harikrishnan S Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345 [TBL] [Abstract][Full Text] [Related]
36. The effect of stopping dapsone treatment for two months and then restarting it in full dosage in patients with moderately severe erythema nodosum leprosum. Pearson JM; Helmy HS Lepr Rev; 1973 Jun; 44(2):75-82. PubMed ID: 4733886 [No Abstract] [Full Text] [Related]
37. Bacteriological effect of Lamprene (clofazimine) in lepromatous leprosy (report of one year's treatment of 44 patients with 100 mg of Lamprene daily). Leiker DL; Blenska W; Carling D; Fitzherbert M; Larssen P Lepr Rev; 1971 Jun; 42(2):125-30. PubMed ID: 4948481 [No Abstract] [Full Text] [Related]
38. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy. Chandorkar AG; Burte NP; Gade RK; Bulakh PM Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381 [TBL] [Abstract][Full Text] [Related]